Langer A - Search Results

1

A chronically implanted system for automatic defibrillation in active conscious dogs. Experimental model for treatment of sudden death from ventricular fibrillation.

Mirowski M, Mower MM, Langer A, Heilman MS, Schreibman J. Mirowski M, et al. Among authors: langer a. Circulation. 1978 Jul;58(1):90-4. doi: 10.1161/01.cir.58.1.90. Circulation. 1978. PMID: 647893

2

Lead systems for internal ventricular fibrillation.

Deeb GM, Griffith BP, Thompson ME, Langer A, Heilman MS, Hardesty RL. Deeb GM, et al. Among authors: langer a. Circulation. 1981 Aug;64(2):242-5. doi: 10.1161/01.cir.64.2.242. Circulation. 1981. PMID: 7249292

3

Considerations in the development of the automatic implantable defibrillator.

Langer A, Heilman MS, Mower MM, Mirowski M. Langer A, et al. Med Instrum. 1976 May-Jun;10(3):163-7. Med Instrum. 1976. PMID: 1272092

4

The automatic implantable defibrillator. New Modality for treatment of life-threatening ventricular arrhythmias.

Mirowski M, Mower MM, Reid PR, Watkins L, Langer A. Mirowski M, et al. Among authors: langer a. Pacing Clin Electrophysiol. 1982 May;5(3):384-401. doi: 10.1111/j.1540-8159.1982.tb02246.x. Pacing Clin Electrophysiol. 1982. PMID: 6179057

5

Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Mirowski M, et al. Among authors: langer a. N Engl J Med. 1980 Aug 7;303(6):322-4. doi: 10.1056/NEJM198008073030607. N Engl J Med. 1980. PMID: 6991948 Clinical Trial. No abstract available.

6

Pharmacologic and pathologic effects of an automatic implantable defibrillator.

Deeb GM, Hardesty RL, Thompson ME, Langer A, Heilman MS. Deeb GM, et al. Among authors: langer a. Trans Am Soc Artif Intern Organs. 1981;27:1-6. Trans Am Soc Artif Intern Organs. 1981. PMID: 7331060 No abstract available.

7

Engineering considerations in the development of the automatic implantable cardioverter defibrillator.

Kolenik SA, Langer AA, Heilman MS, Staewen WS. Kolenik SA, et al. Among authors: langer aa. Prog Cardiovasc Dis. 1993 Sep-Oct;36(2):115-36. doi: 10.1016/0033-0620(93)90004-w. Prog Cardiovasc Dis. 1993. PMID: 8367608

8

Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.

Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW. Goodman SG, et al. Among authors: langer a. Circulation. 1998 Feb 10;97(5):444-50. doi: 10.1161/01.cir.97.5.444. Circulation. 1998. PMID: 9490238 Clinical Trial.

9

Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.

Singh N, Mironov D, Armstrong PW, Ross AM, Langer A. Singh N, et al. Among authors: langer a. Circulation. 1996 Apr 1;93(7):1388-95. doi: 10.1161/01.cir.93.7.1388. Circulation. 1996. PMID: 8641028

10

Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.

Langer A, Minkowitz J, Dorian P, Casella L, Harris L, Morgan CD, Armstrong PW. Langer A, et al. J Am Coll Cardiol. 1992 Nov 15;20(6):1313-7. doi: 10.1016/0735-1097(92)90242-f. J Am Coll Cardiol. 1992. PMID: 1430680 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

834 results

Search Page